Communications BiologyImmunologyPeer-reviewed journal article
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domain
Mera F. Liccione, Trevor ScobeyiD, Heather M. FroggattiD, Camryn Pajon, Boyd L. YountiD, Qi Yin, Taylor N. Spence, Emmanuel B. Walter, Kevin O. SaundersiD, Robert J. EdwardsiD, Ralph Steven BariciD, Barton F. HaynesiD, Derek W. CainiD, Timothy Patrick SheahaniD, Daniel WrappiD
Abstract
HCoV-229E is an endemic Alphacoronavirus that typically causes common cold-like disease in most healthy adults, but can also cause severe respiratory disease in the very young and the elderly. Although the virus was discovered over sixty years ago and undergoes continuous antigenic drift, remarkably little is known about the humoral immune response to HCoV-229E infection. Here we report the isolation of two receptor binding domain-targeting neutralizing human antibodies raised in response to natural HCoV-229E infection. One of these, DH1533, potently neutralizes HCoV-229E, binds to spike with sub-nanomolar affinity and prevents the association between the RBD and the host cell receptor aminopeptidase N. Structural characterization of this antibody bound to HCoV-229E spike delineated a neutralization-sensitive epitope on the RBD and revealed that DH1533 induces conformational flexibility in neighboring RBDs, reminiscent of the "up-and-down" kinetics observed in the related Betacoronavirus spikes. These findings provide insight into the humoral immune response to HCoV-229E infection and will serve as a guide for the design of future therapeutic interventions.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 48%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mutations to the HCoV-229E spike have counterbalancing effects on serum antibody neutralization and receptor binding
Sheri Harari, Rachel T. Eguia, … Jesse D. Bloom·bioRxiv·Feb 23, 2026
- Molecular basis for antiviral activity of pediatric neutralizing antibodies targeting SARS-CoV-2 Spike receptor binding domain
Y. Chen, J. Prevost, … A. Finzi·bioRxiv·Jul 27, 2022
- Structural Definition of Neutralizing Epitopes within and around the HKU1 Receptor-binding Site Reveals Cell Context-Dependent Neutralization
Jeswin Joseph, Lingshu Wang, … Kizzmekia S. Corbett·bioRxiv·Oct 29, 2025
- Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins
Y. Shi, J. Shi, … G. Peng·Journal of VirologyPeer-reviewed·Mar 10, 2021
- The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera.
T. Steffen, E. T. Stone, … J. D. Brien·bioRxiv·Aug 21, 2020
- Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor